Guardian Connect (glucose monitoring)

Main articles:

• CRM (Customer Relationship Management System)
• Mobile applications

The Guardian Connect system allows the people receiving daily injections of insulin to check at any time the current level of glucose in blood using the mobile device. Notifications on high and low levels of glucose can also come to the mobile device that helps to avoid similar situations or it is effective to react to them.

2020: Entry into the Russian market

On September 16, 2020 Medtronic plc presented at the Russian market the system of continuous monitoring of Guardian Connect glucose which allows people to monitor with the diabetes doing several injections of insulin in day sugar level in blood 24/7. Users of the Guardian Connect system can check at any time the current level of glucose in blood using the mobile device — it is not more difficult to make it, than to obtain information from usual sources, such as e-mail, weather forecast or social networks.

Guardian Connect is a monitoring system of glucose with function of SMS notifications. Thanks to this opportunity the attending physician or the loved one (relative) can receive notifications on high and low levels of glucose in the patient's blood on any connected mobile device. A system is capable to load data into the CareLink program managing treatment process daily automatically. It simplifies a problem of data loading both for the patient, and for the doctor.

The Guardian Connect system with function of the continuous monitoring of glucose (CMG) consists of the small sensor which measures concentration of glucose in blood each five minutes (288 times a day), and the transmitter transferring collected data on glucose to the mobile device. The solution allows patients to check with diabetes glucose level on the mobile phone. At the same time they can monitor fluctuations of this indicator in real time, define its dynamics and increase effective management of a disease. Notifications can be configured so that to receive them at a glucose level exit for previously set limits that helps patients to prevent such potentially dangerous situations or in time to react to them.

The hidden hypoglycemia is a permanent danger in life of people with diabetes, especially those who are on insulin therapy (enters several doses of insulin in day). It is very important to have exact and available data of continuous monitoring of glucose for safe achievement of the glycemic purposes, - doctor Timothy Bailey, the director of the research center AMCR (USA) says. — By my experience, people more likely use NMG when they can see these data on the favourite device — the mobile phone. Thus, with the NMG Guardian Connect system becomes more available.

The Guardian Connect application is available to devices based on OS iOS and Android.

2018: Beginning of sales

On March 12, 2018 the Medtronic company announced the beginning of sales of a system for the continuous monitoring of a glycemia (CMG) of Guardian Connect intended to patients who inject insulin several times a day.

Some medical institutions with which Medtronic cooperates had an opportunity to purchase Guardian Connect. The solution will go on free sale in May-June, 2018.

The Guardian Connect system consists of the Guardian 3 sensor and the transmitter which sends collected data through Bluetooth to the Guardian Connect application on the user's smartphone. The application is capable to warn the patient about the high or low level of sugar in blood in 60 minutes prior to hyper - or a hypoglycemia.

Guardian Connect

Despite the proved advantages, very small share of patients with insulin-dependent diabetes uses technologies of continuous monitoring of a glycemia, - Dr. Timothy Bailey, the director of institute of AMCR in the press release of Medtronic explained. - The latest sensors in combination with intellectual algorithms allow to reveal deviations in the level of glucose and moreover, to predict them that reduces risk dangerous hypo - and a hyperglycemia at the patients receiving insulin.

A system also includes the system of recommendations Sugar.IQ developed by IBM Watson; the company provided it in 2016. This system makes to users individual recommendations about a diet and remedial gymnastics on the basis of data retrieveds about glucose level.

The only question which disturbs the patient: "How many insulin I need to enter?", - Huzefa Neemukhvala, the senior director on innovations in the field of information science of Medtronic says. - And it is the only question which the doctor cannot directly answer because the required dose of insulin depends on many factors. But the automated system is capable to analyze these factors and to tell: "in similar circumstances you used such dose of insulin". And this answer will be closest to real.

2016

Obtaining certificate of CE

In July, 2016 the Medtronic company announced that its new mobile system of continuous monitoring of level of Guardian Connect glucose for the people with diabetes receiving treatment in the form of subcutaneous injections of insulin received the certificate of CE (Conformité Européenne is the European compliance).

It is announced that a system will be started in the second quarter 2017 financial year, since a number of the countries of Europe, the Pacific Rim and Latin America.

Originally the Guardian Connect application will be released for devices based on iOS. The application version is developed for Android OS at this time and will be submitted later. In the USA the Guardian Connect system for July, 2016 is not on sale.

"To people with diabetes very important continuously, in real time to monitor glucose level in blood and to receive notifications on significant changes of this indicator and other important events. Announcing the new Guardian Connect system, we continue a course towards development of innovations that the people with diabetes using a method of introduction of injections of insulin could manage a disease more effectively, – Annette Brüls, the president of division "Services and solutions for treatment of diabetes" noted Medtronic companies. – The Guardian Connect system is also compatible to our software platform of management of CareLink® diabetes that gives the chance to doctors and patients more effectively to control a disease. Our task – to help the bigger number of people with diabetes that they felt more free and healthy".

Description of Guardian Connect

Guardian Connect is the first and for July, 2016 the only monitoring system of glucose with function of SMS notifications. Thanks to this opportunity the patient or the doctor can receive notifications on high and low levels of glucose in blood on any connected mobile device. A system is capable to load data into the CareLink program managing treatment process daily automatically. It simplifies a problem of data loading for the people receiving insulin injections and also for medical institutions which services such patients use.

The Guardian Connect system consists of the NMG small wearable device which measures concentration of glucose in blood each five minutes (288 times a day) and sends collected data to the application on the smartphone. The solution allows the people receiving insulin injections to check glucose level from the mobile phone. At the same time they can monitor fluctuations of this indicator in real time, define its dynamics and increase effective management of a disease. Notifications can be configured so that to receive them at a glucose level exit for previously set limits that helps patients to prevent such potentially dangerous situations or in time to react to them. All this information can be transferred to the partners participating in treatment process by means of Sms. Besides, it is possible to provide them access to statistics of NMG updated in real time on any mobile device with a connectivity to the Internet. And at last, medical institutions can use data which are daily automatically loaded into the CareLink system.